Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development

被引：136
作者：
Bigal, Marcelo E. [1 ]
Walter, Sarah [2 ]
Rapoport, Alan M. [3 ]
机构：
[1] Labrys Biol Inc, San Mateo, CA 94404 USA
[2] Labrys Biol Inc, Preclin Res, San Mateo, CA 94404 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
来源：
HEADACHE | 2013年 / 53卷 / 08期
关键词：
calcitonin gene-related peptide; antibodies; migraine; chronic migraine; RANDOMIZED CONTROLLED-TRIAL; ISOLATED CORONARY-ARTERY; MENINGEAL BLOOD-FLOW; RECEPTOR ANTAGONIST; SUBSTANCE-P; SPINAL-CORD; BRAIN-STEM; ALPHA-CGRP; BETA-CGRP; EXTRACEREBRAL CIRCULATION;
D O I：
10.1111/head.12179
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Calcitonin gene-related peptide (CGRP) is a ubiquitous neuropeptide found at the very centers of the migraine process, both centrally and peripherally. It has been under careful study for approximately 25 years. Several CGRP-receptor antagonists are being evaluated for acute treatment of episodic migraine. Three monoclonal antibodies are being studied for prevention of episodic migraine, and 1 monoclonal antibody is being studied for prevention of chronic migraine. In this review, we discuss the role of CGRP in normal physiology and the consequences of CGRP inhibition for human homeostasis. We then review the current state of development for CGRP-receptor antagonists and CGRP monoclonal antibodies. We close by speculating on the potential clinical role of CGRP antagonism in the acute and preventive treatment of episodic and chronic migraine.
引用
收藏
页码：1230 / 1244
页数：15
相关论文
共 114 条
[91]  
Services UDoHaH Administration FaD (CDER) CfDEaR (CBER) CfBEaR, 1997, GUID IND S6 PRECL SA
[92]  
Services USDoHaH Administration FaD (CDER) CfDEaR (CBER) CfBEaR, 1994, GUID IND M3R2 NONCL
[93]   PLASTICITY OF CALCITONIN-GENE-RELATED PEPTIDE NEUROTRANSMISSION IN THE SPINAL-CORD DURING PERIPHERAL INFLAMMATION [J].
SEYBOLD, VS ;
GALEAZZA, MT ;
GARRY, MG ;
HARGREAVES, KM .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (07) :1007-1014
[94]   Emerging Target-Based Paradigms to Prevent and Treat Migraine [J].
Silberstein, S. D. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (01) :78-85
[95]   Removing barriers to appropriate migraine treatment: Formulary limitations and triptan package size [J].
Silberstein, SD ;
Dodick, D ;
Kesslick, J .
HEADACHE, 2005, 45 (09) :1250-1254
[96]   Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974) [J].
Sinclair, Simon R. ;
Kane, Stefanie A. ;
Van der Schueren, Bart J. ;
Xiao, Alan ;
Willson, Kenneth J. ;
Boyle, Janet ;
de Lepeleire, Inge ;
Xu, Yang ;
Hickey, Lisa ;
Denney, William S. ;
Li, Chi-Chung ;
Palcza, John ;
Vanmolkot, Floris H. M. ;
Depre, Marleen ;
Van Hecken, Anne ;
Murphy, M. Gail ;
Ho, Tony W. ;
de Hoon, Jay N. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (01) :15-22
[97]   The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin [J].
Sun, RQ ;
Lawand, NB ;
Willis, WD .
PAIN, 2003, 104 (1-2) :201-208
[98]   Calcitonin gene-related peptide and substance P contribute to reduced blood pressure in sympathectomized rats [J].
Supowit, SC ;
Ethridge, RT ;
Zhao, H ;
Katki, KA ;
DiPette, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (03) :H1169-H1175
[99]   DISTRIBUTION AND ORIGIN OF CALCITONIN GENE-RELATED PEPTIDE (CGRP) IMMUNOREACTIVITY IN THE SENSORY INNERVATION OF THE MAMMALIAN EYE [J].
TERENGHI, G ;
POLAK, JM ;
GHATEI, MA ;
MULDERRY, PK ;
BUTLER, JM ;
UNGER, WG ;
BLOOM, SR .
JOURNAL OF COMPARATIVE NEUROLOGY, 1985, 233 (04) :506-516
[100]   INVESTIGATION OF THE STRUCTURE ACTIVITY RELATIONSHIP OF HUMAN CALCITONIN GENE-RELATED PEPTIDE (CGRP) [J].
TIPPINS, JR ;
DIMARZO, V ;
PANICO, M ;
MORRIS, HR ;
MACINTYRE, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (03) :1306-1311
3456789101112